Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine in Pulmonary Hypertension and Right Ventricular Dysfunction
NCT02829034Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Jul 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ranolazine in pulmonary hypertension (PH), sponsored by University of Pennsylvania. Started Jul 2016; status: completed.
02
Drugs
ranolazine
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT02829034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02829034.